7:00 am - 7:15 am

Industry Sponsored Short Snapper Session #1-A

Treat Early with Biologics

Dr. Mark Silverberg graduated from the University of Toronto Faculty of Medicine in 1992 and completed his internal medicine and gastroenterology training there in 1997. He then obtained his PhD studying the genetics of inflammatory bowel disease (IBD) in 2002 at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital. He is currently a Professor in the Department of Medicine at the University of Toronto, a clinician-scientist in the Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital and a practicing gastroenterologist in the Inflammatory Bowel Disease Group.

Dr. Silverberg’s medical practice is devoted to the care of patients with IBD and IBD makes up the majority of his clinical work. He is an active researcher and scientist searching for causes of IBD and also leads clinical trials and clinical research studies in IBD to help improve management and therapy of patients affected by IBD. He is also heavily engaged in training physicians and other allied health staff about the management of IBD.

Dr. Silverberg is an internationally recognized clinician and leader in the field of IBD and lectures around the world. He is an elected member of the International Organization for the study of Inflammatory Bowel Disease (IOIBD), runs a research centre of the NIH IBD Genetics Consortium and is an active participant in the International IBD Consortium. He is the co-chair of the Canadian GI Fellows Program in IBD and the Program Director of the Advanced IBD Fellowship at Mount Sinai. Fellows and students come from around the world to train in this program with the MSH IBD Group.